See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $22.5B | 1.4x | 6.3x | |
| $16.8B | 15.4x | 49.0x | |
| $16.7B | 10.8x | 33.0x | |
| $9.3B | 3.0x | 7.6x | |
| $7.1B | 9.4x | 36.3x | |
| $6.4B | 4.2x | 21.3x | |
| $3.5B | 1.7x | 9.6x | |
| $3.2B | 1.6x | 10.5x | |
| $3.0B | 2.4x | 8.9x | |
| $2.3B | 8.9x | 21.9x | |
| $2.3B | 8.5x | 17.0x | |
| $1.6B | 6.8x | 27.5x | |
| $1.6B | n/a | n/a | |
| $1.2B | 1.1x | 4.3x | |
| $1.1B | 2.1x | 10.7x | |
| $1.0B | n/a | n/a | |
| $976M | 4.0x | 10.3x | |
| $963M | 7.2x | 27.1x | |
| $896M | 6.2x | 17.8x | |
| $860M | n/a | n/a | |
| $747M | n/a | n/a | |
| $607M | 1.4x | 6.4x | |
| $528M | 2.2x | 9.3x | |
| $513M | 4.0x | 14.8x | |
| $464M | 1.4x | n/a | |
| $448M | n/a | n/a | |
| $324M | n/a | n/a | |
| $174M | 2.8x | n/a | |
| $120M | 1.8x | 8.4x | |
| $95.3M | n/a | n/a | |
| $24.8M | n/a | n/a | |
| $19.5M | 0.9x | -37.9x | |
| $14.5M | n/a | n/a | |
| $11.0M | 5.3x | -1.0x | |
| -$4.1M | n/a | n/a | |
| -$20.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals